載入...

Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis

OBJECTIVES: To examine whether treatment with anti‐tumour necrosis factor (TNF) α prevents loss of bone mineral density (BMD) at the spine and hip (generalised) and in the hands (local) of patients with rheumatoid arthritis, and to study the changes in markers of bone metabolism, including receptor...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Vis, M, Havaardsholm, E A, Haugeberg, G, Uhlig, T, Voskuyl, A E, van de Stadt, R J, Dijkmans, B A C, Woolf, A D, Kvien, T K, Lems, W F
格式: Artigo
語言:Inglês
出版: BMJ Group 2006
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC1798341/
https://ncbi.nlm.nih.gov/pubmed/16606653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.044198
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!